(Q48537424)

English

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure

scientific article published on February 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1560266

9 October 2022

1 reference

based on heuristic

inferred from title

author name string

A. M. Spence

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1560266

9 October 2022

M. S. Berger

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1560266

9 October 2022

R. B. Livingston

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1560266

9 October 2022

F. Ali-Osman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1560266

9 October 2022

B. Griffin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1560266

9 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1560266

9 October 2022

publication date

1 February 1992

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

12

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

187-191

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

https://scigraph.springernature.com/pub.10.1007/bf00172671

0 references

Intra-arterial cisplatin for the treatment of malignant gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modalities of cisplatin administration to brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracarotid cisplatin chemotherapy for recurrent gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual system toxicity following intra-arterial chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1560266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00172671

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/1560266

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48537424&oldid=1746340972"